ArticleCancer immunology, immunotherapy : CII2023

Cisplatin resistance driver claspin is a target for immunotherapy in urothelial carcinoma.

Shuhei Yamada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.